North Rock Partners, LLC Amgen Inc Transaction History

North Rock Partners, LLC

  • $1.18 Billion
  • Q1 2024

A detailed history of North Rock Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, North Rock Partners, LLC holds 4,647 shares of AMGN stock, worth $1.44 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,647
Previous 4,104 13.23%
Holding current value
$1.44 Million
Previous $1.18 Million 11.76%
% of portfolio
0.11%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$268.87 - $324.56 $145,996 - $176,236
543 Added 13.23%
4,647 $1.32 Million
Q4 2023

Feb 08, 2024
BUY
$255.7 - $288.46 $61,368 - $69,230
240 Added 6.21%
4,104 $1.18 Million
Q3 2023

Oct 24, 2023
BUY
$218.65 - $271.46 $407,563 - $506,001
1,864 Added 93.2%
3,864 $1.04 Million
Q2 2023

Aug 02, 2023
SELL
$214.27 - $253.37 $105,635 - $124,911
-493 Reduced 19.78%
2,000 $444,000
Q1 2023

May 03, 2023
SELL
$225.79 - $275.2 $74,510 - $90,816
-330 Reduced 11.69%
2,493 $602,000
Q4 2022

Feb 01, 2023
BUY
$229.03 - $291.01 $32,522 - $41,323
142 Added 5.3%
2,823 $741,000
Q3 2022

Nov 02, 2022
SELL
$224.46 - $253.15 $345,892 - $390,104
-1,541 Reduced 36.5%
2,681 $604,000
Q2 2022

Aug 04, 2022
BUY
$230.71 - $256.74 $354,370 - $394,352
1,536 Added 57.19%
4,222 $1.03 Million
Q1 2022

May 05, 2022
BUY
$219.27 - $242.57 $231,768 - $256,396
1,057 Added 64.89%
2,686 $650,000
Q4 2021

Feb 07, 2022
BUY
$198.88 - $227.6 $35,002 - $40,057
176 Added 12.11%
1,629 $367,000
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $73,657 - $86,298
347 Added 31.37%
1,453 $309,000
Q2 2021

Aug 12, 2021
BUY
$233.58 - $259.14 $258,339 - $286,608
1,106 New
1,106 $270,000
Q4 2020

Feb 08, 2021
SELL
$216.38 - $257.67 $201,666 - $240,148
-932 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $18,772 - $20,876
80 Added 9.39%
932 $237,000
Q2 2020

Aug 13, 2020
SELL
$197.81 - $242.74 $395 - $485
-2 Reduced 0.23%
852 $201,000
Q2 2020

Aug 11, 2020
SELL
$197.81 - $242.74 $132,334 - $162,393
-669 Reduced 43.93%
854 $201,000
Q1 2020

May 13, 2020
SELL
$182.24 - $241.7 $189,711 - $251,609
-1,041 Reduced 40.6%
1,523 $309,000
Q4 2019

Feb 12, 2020
SELL
$189.21 - $243.2 $189 - $243
-1 Reduced 0.04%
2,564 $618,000
Q4 2019

Feb 12, 2020
BUY
$189.21 - $243.2 $217,780 - $279,923
1,151 Added 81.4%
2,565 $618,000
Q3 2019

Nov 12, 2019
BUY
$174.11 - $208.62 $246,191 - $294,988
1,414 New
1,414 $274,000

Others Institutions Holding AMGN

# of Institutions
2,933
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email